Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Circulating DNA, Circulating RNA, Circulating Tumor Cells

Theresa Zhang's Biography

Theresa Zhang, Vice President, Research Services, Personal Genome Diagnostics

Dr. Zhang joined PGDx from Merck Research Laboratories, where she held positions of increasing responsibility for predictive biomarker identification and clinical implementation for oncology compounds for over a decade. During her tenure at Merck, Dr. Zhang oversaw the development of specially designed CLIA assays for use in cancer clinical trials and advanced a number of candidate biomarkers for clinical validation. She also managed multiple external collaborations. Dr. Zhang received BS degrees from Peking University and Bridgewater College and a PhD from the University of Virginia. She completed a Postdoctoral Fellowship in bioinformatics at Cold Spring Harbor Laboratories. Dr. Zhang is a co-author of numerous scientific publications and a frequent presenter at scientific meetings.

Theresa Zhang Image

Methods for Comprehensive Genomic Analysis of Genetic Alterations in Circulation of Cancer Patients

Tuesday, 24 March 2015 at 13:30

Add to Calendar ▼2015-03-24 13:30:002015-03-24 14:30:00Europe/LondonMethods for Comprehensive Genomic Analysis of Genetic Alterations in Circulation of Cancer

  • Development of PlasmaSelect for the detection of clinically relevant sequence mutations and translocations across a large number of genomic loci
  • Development of METDetect for the ultra-sensitive detection of focal amplification of MET in plasma
  • Case studies of utilizing circulating tumor DNA analysis to support clinical decisions and drug development

Add to Calendar ▼2015-03-23 00:00:002015-03-24 00:00:00Europe/LondonCirculating DNA, Circulating RNA, Circulating Tumor